176 related articles for article (PubMed ID: 14962714)
41. Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain.
De-Fraja C; Conti L; Magrassi L; Govoni S; Cattaneo E
J Neurosci Res; 1998 Nov; 54(3):320-30. PubMed ID: 9819137
[TBL] [Abstract][Full Text] [Related]
42. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
[TBL] [Abstract][Full Text] [Related]
43. Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors.
Cwikel S; Silvian-Drachsler I; Prolov L; Hooghe-Peters EL; Merchav S
Exp Hematol; 2001 Aug; 29(8):937-42. PubMed ID: 11495699
[TBL] [Abstract][Full Text] [Related]
44. Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.
Sasi W; Jiang WG; Sharma A; Mokbel K
BMC Cancer; 2010 Apr; 10():178. PubMed ID: 20433750
[TBL] [Abstract][Full Text] [Related]
45. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
[TBL] [Abstract][Full Text] [Related]
46. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538
[TBL] [Abstract][Full Text] [Related]
47. Induction of the interleukin-2/15 receptor beta-chain by the EWS-WT1 translocation product.
Wong JC; Lee SB; Bell MD; Reynolds PA; Fiore E; Stamenkovic I; Truong V; Oliner JD; Gerald WL; Haber DA
Oncogene; 2002 Mar; 21(13):2009-19. PubMed ID: 11960373
[TBL] [Abstract][Full Text] [Related]
48. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.
Bright JJ; Kerr LD; Sriram S
J Immunol; 1997 Jul; 159(1):175-83. PubMed ID: 9200453
[TBL] [Abstract][Full Text] [Related]
49. In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2.
Flores-Morales A; Pircher TJ; Silvennoinen O; Gustafsson JA; Sanchez-Gomez M; Norstedt G; Haldosén LA; Wood TJ
Mol Cell Endocrinol; 1998 Mar; 138(1-2):1-10. PubMed ID: 9685210
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors.
Callus BA; Mathey-Prevot B
Blood; 1998 May; 91(9):3182-92. PubMed ID: 9558373
[TBL] [Abstract][Full Text] [Related]
51. Delineation of the regions of interleukin-2 (IL-2) receptor beta chain important for association of Jak1 and Jak3. Jak1-independent functional recruitment of Jak3 to Il-2Rbeta.
Zhu MH; Berry JA; Russell SM; Leonard WJ
J Biol Chem; 1998 Apr; 273(17):10719-25. PubMed ID: 9553136
[TBL] [Abstract][Full Text] [Related]
52. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.
Fujii H; Nakagawa Y; Schindler U; Kawahara A; Mori H; Gouilleux F; Groner B; Ihle JN; Minami Y; Miyazaki T
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5482-6. PubMed ID: 7777534
[TBL] [Abstract][Full Text] [Related]
53. Interleukin-7 receptor expression and activation in nonhaematopoietic neoplastic cell lines.
Cosenza L; Gorgun G; Urbano A; Foss F
Cell Signal; 2002 Apr; 14(4):317-25. PubMed ID: 11858939
[TBL] [Abstract][Full Text] [Related]
54. Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity.
Gaffen SL; Lai SY; Ha M; Liu X; Hennighausen L; Greene WC; Goldsmith MA
J Biol Chem; 1996 Aug; 271(35):21381-90. PubMed ID: 8702919
[TBL] [Abstract][Full Text] [Related]
55. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line.
To KF; Chan MW; Leung WK; Ng EK; Yu J; Bai AH; Lo AW; Chu SH; Tong JH; Lo KW; Sung JJ; Chan FK
Br J Cancer; 2004 Oct; 91(7):1335-41. PubMed ID: 15354212
[TBL] [Abstract][Full Text] [Related]
56. Defective interleukin-2-dependent STAT5 signalling in CD8 T lymphocytes from HIV-positive patients: restoration by antiretroviral therapy.
Kryworuchko M; Pasquier V; Keller H; David D; Goujard C; Gilquin J; Viard JP; Joussemet M; Delfraissy JF; Thèze J
AIDS; 2004 Feb; 18(3):421-6. PubMed ID: 15090793
[TBL] [Abstract][Full Text] [Related]
57. The activation of the JAK2/STAT5 pathway is commonly involved in signaling through the human IL-5 receptor.
Ogata N; Kikuchi Y; Kouro T; Tomonaga M; Takatsu K
Int Arch Allergy Immunol; 1997 Oct; 114 Suppl 1():24-7. PubMed ID: 9363920
[TBL] [Abstract][Full Text] [Related]
58. Signaling via the IL-2 and IL-7 receptors from the membrane to the nucleus.
Leonard WJ; Imada K; Nakajima H; Puel A; Soldaini E; John S
Cold Spring Harb Symp Quant Biol; 1999; 64():417-24. PubMed ID: 11232316
[No Abstract] [Full Text] [Related]
59. High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer.
Salhab M; Patani N; Jiang W; Mokbel K
Breast Cancer; 2012 Apr; 19(2):153-60. PubMed ID: 20972741
[TBL] [Abstract][Full Text] [Related]
60. TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways.
Kanie T; Abe A; Matsuda T; Kuno Y; Towatari M; Yamamoto T; Saito H; Emi N; Naoe T
Leukemia; 2004 Mar; 18(3):548-55. PubMed ID: 14749700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
